Shantou MEBO Pharmaceutical

Shantou MEBO Pharmaceutical is a core manufacturing and research subsidiary of the MEBO Group, specializing in regenerative medicine and advanced wound care. Founded based on the Regenerative Restoration Method developed by Dr. Rongxiang Xu, the company is globally recognized for its flagship product, Moist Exposed Burn Ointment (MEBO), which facilitates in situ skin regeneration. The company's business model focuses on the development of botanical-based pharmaceuticals and health products that activate the body's innate regenerative potential. Operating from large-scale GMP-certified facilities in Shantou, China, the company produces a variety of topical ointments and oral capsules for dermatology and gastroenterology. Shantou MEBO Pharmaceutical serves as a critical hub for the production and distribution of regenerative therapies to over 70 countries.